Angiotensin II: a devious activator of mineralocorticoid receptor-dependent gene expression.
Blaxall
Burns C
BC
Miano
Joseph M
JM
Berk
Bradford C
BC
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000096:biosynthesis / Q000235:genetics; D000375:Aging / Q000502:physiology; D000450:Aldosterone / Q000494:pharmacology / Q000502:physiology; D000804:Angiotensin II / Q000494:pharmacology / Q000502:physiology*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D017382:Reactive Oxygen Species; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology; D018161:Receptors, Mineralocorticoid / Q000096:biosynthesis / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D015533:Transcriptional Activation
D017382:Reactive Oxygen Species; D044140:Receptor, Angiotensin, Type 1; D018161:Receptors, Mineralocorticoid; D000804:Angiotensin II; D000450:Aldosterone; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2